BinitaShahAsharMD, MBA, FACS

Director, Office of Surgical and Infection Control Devices US FDA

Dr. Ashar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10903 New Hampshire Ave
Hfz-410
Silver Spring, MD 20993
Phone+1 301-796-6385

PubMed

88 citations
Trocar-associated injuries and fatalities: an analysis of 1399 reports to the FDA.
Janie Fuller, Binita S. Ashar, Julia Carey-Corrado
Journal of Minimally Invasive Gynecology. 2005-08-01
82 citations
Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018.
Colleen M. McCarthy, Nilsa Loyo-Berrios, Ali A Qureshi, Erin Mullen, Gayle M. Gordillo
Plastic and Reconstructive Surgery. 2019-03-01
49 citations
Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Elaine S. Jaffe, Binita S. Ashar, Mark W. Clemens, Andrew L. Feldman, Philippe Gaulard
Journal of Clinical Oncology. 2020-02-11

FDA Orders New Restrictions, Stronger Warnings for Breast ImplantsOctober 28th, 2021
Health Highlights: April 1, 2021April 1st, 2021
FDA Authorizes First Surgical Robot to Help with Transvaginal HysterectomiesMarch 1st, 2021
Join now to see all